A positive amyloid trial, finally?

Big Alzheimer’s disease news this week: positive results for an anti-amyloid therapy. Researcher Derek Lowe takes a more sober view: “As the world knows, the anti-amyloid clinical landscape for Alzheimer’s is absolutely littered with failures in every direction: anti-amyloid antibodies of various types, attempts to inhibit beta-secretase and gamma-secretase enzymes, attempts to prevent aggregation, you name it. Nothing has worked.” | learn more